Cargando…

Prediction of major bleeding events in 1381 patients with essential thrombocythemia

The goal of therapy in essential thrombocythemia (ET) is reducing thrombotic risk. No algorithm to predict hemorrhage risk exists. The impact ofanti-platelet, cytoreductive and anticoagulation therapies on risk of major bleeding (MB) was evaluated. MB events were retrospectively analyzed in 1381 ET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stuckey, Ruth, Ianotto, Jean-Christophe, Santoro, Marco, Czyż, Anna, Encinas, Manuel M. Perez, Gómez-Casares, María Teresa, Pereira, Maria Soledad Noya, de Nałęcz, Anna Kulikowska, Gołos, Aleksandra, Lewandowski, Krzysztof, Szukalski, Łukasz, González-Martín, Jesús M., Sobas, Marta Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615906/ https://www.ncbi.nlm.nih.gov/pubmed/37660316 http://dx.doi.org/10.1007/s12185-023-03650-7

Ejemplares similares

Agreement K 1381
por: The European Organisation for Nuclear Research, CERN, et al.
Publicado: (2007)

Primary Immune Thrombocytopenia and Essential Thrombocythemia: So Different and yet Somehow Similar—Cases Series and a Review of the Literature
por: Sobas, Marta, et al.
Publicado: (2021)

Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia
por: Alvarez-Larrán, Alberto, et al.
Publicado: (2023)

1381. Barriers and Facilitators to Prompt Diagnosis of Tuberculosis in Lima, Peru
por: Geadas, Carolina, et al.
Publicado: (2023)

1381. Impact of Total Body Weight on Efficacy of Ceftriaxone in Obese Patients
por: Wagner, Jamie L, et al.
Publicado: (2018)

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs
por: Sobas, Marta, et al.
Publicado: (2022)

Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding
por: Awada, Hassan, et al.
Publicado: (2020)

1381. M.genavense in the ART Era: From Persistent Disseminated Disease to Severe Disease
por: Manion, Maura, et al.
Publicado: (2019)

The role of fluconazole in the regulation of fatty acid and unsaponifiable matter biosynthesis in Schizochytrium sp. MYA 1381
por: Li, Jun, et al.
Publicado: (2019)

1381. Rotavirus Gastroenteritis among older adults: discussion based on a systematic literature review
por: Carias, Cristina, et al.
Publicado: (2020)

P1381: DISTINCT CYTOKINE SIGNATURES OF IDECABTAGENE VICLEUCEL COMPARED TO AXICABTAGENE CILEUCEL AND LISOCABTAGENE MARALEUCEL
por: Mirza, Abu-Sayeef, et al.
Publicado: (2023)

Easily Applicable Predictive Score for Differential Diagnosis of Prefibrotic Primary Myelofibrosis from Essential Thrombocythemia
por: Lekovic, Danijela, et al.
Publicado: (2023)

Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review
por: Ianotto, Jean-Christophe, et al.
Publicado: (2019)

Essential Thrombocythemia in Children and Adolescents
por: Putti, Maria Caterina, et al.
Publicado: (2021)

Low-Risk Essential Thrombocythemia: A Comprehensive Review
por: Robinson, Andrew J., et al.
Publicado: (2021)

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)
por: Le Calloch, Ronan, et al.
Publicado: (2018)

HRAS mutation positive multiple myeloma in the type 2 CALR mutation positive essential thrombocythemia: A case report
por: Krzysztof, Lewandowski, et al.
Publicado: (2023)

Essential thrombocythemia
por: Brière, Jean B
Publicado: (2007)

Management of thrombocythemia
por: Gowin, Krisstina, et al.
Publicado: (2014)

1381. Do Gut Microbiome Profiles Correlate with Hospital Length of Stay During Hematopoietic Stem Cell Transplantation?
por: Mendy, Angelico, et al.
Publicado: (2021)

Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report
por: Sobas, M. A., et al.
Publicado: (2017)

Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients
por: Kulikowska de Nałęcz, Anna, et al.
Publicado: (2021)

Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors
por: Kulikowska de Nałęcz, Anna, et al.
Publicado: (2023)

The Essential Thrombocythemia, Thrombotic Risk Stratification, and Cardiovascular Risk Factors
por: Mancuso, Salvatrice, et al.
Publicado: (2020)

Cutaneous manifestation of chronic lymphocytic leukemia: a case report and a literature review
por: Szukalski, Łukasz, et al.
Publicado: (2019)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib
por: Lewandowski, Krzysztof, et al.
Publicado: (2016)

Identification, function, and application of 3-ketosteroid Δ1-dehydrogenase isozymes in Mycobacterium neoaurum DSM 1381 for the production of steroidic synthons
por: Zhang, Ruijie, et al.
Publicado: (2018)

High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis
por: Kanduła, Zuzanna, et al.
Publicado: (2023)

Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic Syndromes
por: Skalska-Bugala, Aleksandra, et al.
Publicado: (2022)

The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease’s phenotype
por: Sobieralski, Patryk, et al.
Publicado: (2023)

A Proliferation-Inducing Ligand and B-Cell Activating Factor Are Upregulated in Patients with Essential Thrombocythemia
por: Bolkun, Lukasz, et al.
Publicado: (2022)

Emerging treatments for essential thrombocythemia
por: Okoli, Steven, et al.
Publicado: (2011)

Thromboembolic complication in Essential Thrombocythemia
por: Mozaheb, Zahra
Publicado: (2012)

Sweet's syndrome with idiopathic thrombocythemia
por: Kaszewski, Sebastian, et al.
Publicado: (2014)

Essential thrombocythemia: Busulphan revisited
por: Koduri, Prasad R.
Publicado: (2016)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

Mutations and thrombosis in essential thrombocythemia
por: Guglielmelli, Paola, et al.
Publicado: (2021)

Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia
por: Santoro, Cristina, et al.
Publicado: (2017)

Whole-Genome Analysis of Mycobacterium neoaurum DSM 1381 and the Validation of Two Key Enzymes Affecting C22 Steroid Intermediates in Sterol Metabolism
por: Zhang, Jingxian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gemqo38dfgfk30qenr270r7al9